Jing Liu
Molecular Biology · with Lin · 2005
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 8 citations into it
- Cancer Research — 6 citations into it
Whom Jing Liu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Jing Liu overall
Papers from Jing Liu's perspective
Ordered by how strongly the researchers Jing Liu trusts endorse each paper. Same corpus, a different order for every researcher.
- Signal transduction by tumor necrosis factor and its relatives. (Trends in Cell Biology)
- Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression (Oncogene)
- Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. (Science)
- Upstream and downstream of mTOR. (Genes & Development)
- Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. (Molecules and Cells)
- Signaling to NF-kappaB. (Genes & Development)
- NF-κB: a key role in inflammatory diseases
- The Hallmarks of Cancer Review
- Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase
- Tumour biology: Herceptin acts as an anti-angiogenic cocktail (Nature)
Their papers
- Role of JNK activation in apoptosis: A double-edged sword (2005) — 708 citations